Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,490
Total Claims
$4.5M
Drug Cost
715
Beneficiaries
$6,340
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-89%
Opioid rate vs peers
0.3% vs 2.6% avg
+494%
Cost per patient vs peers
$6,340 vs $1,068 avg
+140%
Brand preference vs peers
21.6% vs 9.0% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.3%
Opioid Rate
58
Opioid Claims
$153
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 4,339 claims · $4.0M
Generic: 15,727 claims · $539K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 650 | $855K |
| Empagliflozin | 362 | $499K |
| Sitagliptin Phosphate | 230 | $263K |
| Apixaban | 173 | $209K |
| Dulaglutide | 101 | $192K |
| Sitagliptin Phos/Metformin Hcl | 146 | $190K |
| Fluticasone Propion/Salmeterol | 154 | $150K |
| Dapagliflozin Propanediol | 113 | $140K |
| Budesonide/Formoterol Fumarate | 220 | $126K |
| Omeprazole/Sodium Bicarbonate | 47 | $107K |
| Umeclidinium Bromide | 130 | $87K |
| Diclofenac Sodium | 292 | $87K |
| Fluticasone/Umeclidin/Vilanter | 80 | $80K |
| Sacubitril/Valsartan | 51 | $78K |
| Linaclotide | 60 | $72K |
Prescribing Profile
Patient Profile
71
Avg Age
52%
Female
1.63
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About